Postprandial inflammation: targeting glucose and lipids

Area of Science:

• Cardiovascular Science
• Immunology
• Metabolic Health

Background:

• Atherosclerosis development involves numerous risk factors, with inflammation being a critical component of atherosclerotic plaques.
• Emerging evidence implicates postprandial (after-meal) lipoproteins and glucose in initiating the inflammatory processes that precede atherosclerosis.
• The postprandial state involves remnant lipoproteins binding to leukocytes and endothelial cells, triggering acute activation, oxidative stress, and cytokine production.

Purpose of the Study:

• To review the current evidence on the role of postprandial inflammation in atherogenesis.
• To discuss how lifestyle and pharmaceutical interventions can modulate postprandial inflammatory responses.

Main Methods:

• Review of existing scientific literature on postprandial lipoproteins, glucose metabolism, inflammation, and atherosclerosis.
• Analysis of studies investigating the impact of nutrients, lifestyle, and medications on postprandial inflammatory markers.

Main Results:

• Postprandial lipoproteins and elevated glucose levels activate leukocytes and endothelial cells, contributing to endothelial dysfunction, an early defect in atherogenesis.
• Advanced glycation end products, resulting from hyperglycemia, exacerbate inflammation and endothelial damage.
• Limited information exists regarding the specific contribution of different nutrients to postprandial inflammation.

Conclusions:

• Postprandial inflammation, driven by lipoproteins and glucose, is a significant contributor to endothelial dysfunction and atherogenesis.
• Modulating postprandial inflammation through lifestyle and pharmaceutical interventions presents a potential therapeutic strategy for preventing atherosclerosis.